Expansionof trinucleotide repeats has been identified as a common mechanismof hereditary neurodegenerative diseases including spinal and bulbar muscular atrophy (SBMA), Huntington's disease, dentatorubral-pallidoluysian atrophy (DRPLA), Machado-Joseph disease (MJD), fragile Xsyndrome, myotonic dystrophy and Friedreich's ataxia. These diseases share unique features, which are difficult to explain based on Mendelian inheritance. These unique clinical genetic features include genetic anticipation and a broad spectrum of clinical presentations, which have been shown to be associated with the instability of the trinucleotide repeats. Recent studies suggest that gene products with expanded polyglutamine tracts may be toxic to neuronal cells, and the mechanisms ofneurotoxicity should be thoroughly investigated. To develop therapeutic measures, creation of animal modelsor cell culture systems for the investigation of neurotoxicity will be indispensable. (Internal Medicine 36: 3-8, 1997) 
Introduction
Application of molecular genetic approaches to the identification of causative genes has advanced our understanding of the molecular mechanisms of a numberof hereditary neurologic diseases. The approach is called "positional cloning" (1) , which consists of two steps, the first step being identification of the chromosomal localization of the disease gene(s) by linkage analysis, and the second step identification of the causative gene(s) employing various recently developed robust methods to allow analysis of huge DNAmolecules using yeast artificial chromosomesor pulsed field gel electrophoresis, or efficient methods for identification of expressed sequences of genomic segments including direct selection and exon trapping. Amongthe various hereditary neurologic diseases, a distinct group of triplet repeat diseases has been identified to constitute a new class of disease, based on the mechanismunderlying their development. These diseases exhibit unusual clinical as well as genetic features which are difficult to understand on the basis of classical Mendelian inheritance. In this review I will focus on recent developments in the research on triplet repeat diseases.
Classification of Triplet Repeat Diseases
A triplet repeat disease is defined as a disease caused by unstable expansion of a trinucleotide repeat such as a CAG trinucleotide repeat. Interestingly, genes containing trinucleotide repeats are present in normal individuals, with the number of repeat units ranging from several to nearly 40. The presence of an expanded allele with a trinucleotide repeat size exceeding the normal range leads to expression of disease phenotypes. To date, four classes of triplet repeat diseases have been identified based on the location of the triplet repeats in the causative genes. As shown in Fig. 1 , the triplet repeat may be located in the 5'-untranslated region (5'-UTR), 3'-UTR, introns or coding regions.
Expansion of Trinucleotide Repeats in Non-Coding Regions
Fragile X syndrome has been found to be caused by expansion of a CGGtrinucleotide repeat in the 5'-UTR (2-5), while expansion of a CTGtrinucleotide repeat in the 3'-UTR has been found to cause myotonic dystrophy (6) (7) (8) . Expansion of an intronic GAAtrinucleotide repeat has recently been identified in Friedreich's ataxia (9) . The triplet repeats in these diseases are expanded to as manyas several hundred to several thousand repeat units. Fragile X syndrome is an X-linked recessive disease and the leading cause of mental retardation in males (2) (3) (4) (5) characterized by ataxia, decreased or absent tendon reflexes and impairment of deep sensation (9) . Myotonic dystrophy is an autosomal dominant disease affecting multiple organs including muscles and other tissues (6) (7) (8) . The clinical features of myotonic dystrophy include myotonia (prolonged contraction of muscle after voluntary contraction or percussion of the muscle), weakness in distal muscles, cataracts, frontal baldness and endocrine abnormalities. It has been suggested that in fragile X syndrome and Friedreich's ataxia the presence of hugely expanded triplet repeats either in the 5'-UTR or in introns results in decreased efficiency of translation of the causative genes, implying that the disease mechanism is a "loss of function" type of mechanism, which is in accordance with the modeof inheritance of these diseases. However, it is still unknownwhether the levels of mRNA translated from the myotonin kinase gene, the causative gene for myotonic dystrophy, are increased in the muscle of patients with myotonic dystrophy. The product of the FMR1 gene, the causative gene for fragile X syndrome, has been suggested to function as an RNA-binding protein (2) (3) (4) (5) , and that of the myotonin kinase gene to be a protein kinase, based on the nucleotide sequence homology of the myotonin kinase gene to genes encoding other protein kinases (6) (7) (8) (9) . The function of frataxin, the gene product of the gene for Friedreich's ataxia, remains to be elucidated.
Expansion of CAGRepeats in Coding Regions as a CommonMechanism of Neurodegeneration
Expansion of CAGrepeats in protein coding regions was first identified as the causative mutation for spinal and bulbar muscular atrophy (SBMA) (10) . Subsequently expansion of CAGrepeats in protein coding regions has been identified as the causative mutation for Huntington's disease (HD) (1 1), spinocerebellar ataxia type 1 (SCA l ) ( 1 2), dentatorubral-pallidoluysian atrophy (DRPLA) (1 3, 14) and Machado-Joseph disease (MJD) (15) (Fig. 1) . In contrast to the hugely expanded trinucleotide repeats in cases of fragile X syndrome, Friedreich's ataxia or myotonic dystrophy, the expanded CAGrepeats range in size from approximately 40 to 100 repeat units. As mentioned above, to date five diseases have been identi- The onset of these diseases usually occurs in adulthood, but can occur in a wide range of ages from childhood to late adulthood. The clinical manifestations also exhibit a broad spectrum even in a single family. The modeof inheritance of these diseases is autosomal dominant except for SBMA which is inherited as an X-linked recessive trait. There are many similarities among the diseases of this class. 1. The diseases are caused by unstable expansion ofCAGrepeats in coding regions of the causative genes. 2. The CAGrepeats are predicted to code for polyglutamine tracts. 3. The number of CAGrepeat units is variable even amongnormal individuals, in whomit ranges from several to as many as 40. 4. The CAGrepeat is expanded, with the number of repeat units exceeding 40 or so and ranging to as many as 100. The occurrence of CAGrepeats which are largely expanded with the number of repeat units exceeding 1 00 is exceptional. 5. There is a strong inverse correlation between the size of the expanded CAGrepeat and the age at onset. 6. Genetic anticipation, i.e., decreasing age at onset in successive generations, has been identified as a commonphenomenon unique to triplet repeat diseases. 7. Despite the fact that the causative genes are widely expressed, the central nervous system is commonlyand selectively involved, with the distribution of neurodegeneration unique to each disease. 8. The essential feature of the neuropathology associated with the diseases is neurodegeneration or loss of neurons in particular regions of the central nervous system. For example spinal and brain stem motor neurons are selectively involved in SBMA. The functions of the gene products of the genes with CAG repeats remain unknownexcept in the case of the androgen receptor, the gene product of the gene for SBMA.Recent studies suggest that the mutant proteins with expanded polyglutamine tracts have toxic effects on neuronal cells, implying that the disease mechanism is a "gain of function" type of mechanism. In addition to these five triplet repeat diseases, there are a number of diseases exhibiting genetic anticipation of which the causative genes have not been identified. These diseases include various forms of spinocerebellar ataxia, bipolar illness, and schizophrenia (16-19). Therefore, there may be more diseases which are caused by CAGrepeat expansion. Since the conventional approach to the identification of causative genes by positional cloning requires use of large pedigrees for linkage studies, the future development of novel strategies for direct identification of expanded triplet repeats is necessary.
Non-Mendelian Aspects of Triplet Repeat Disease
Variable age at onset Figure 2 shows the correlation between the size of the expanded CAGrepeat of the DRPLAgene and the age of onset ofDRPLA (13, (20) (21) (22) Genetic anticipation Table 1 summarizes the genetic anticipation observed in DRPLA(20-22, 24). Analysis of our data set as well as data in the literature revealed that paternal transmission results in a decrease in age at onset of 26-29 years, while maternal transmission results in a decrease in age at onset of 14-15 years on average (20-2 1 ). There are statistically significant differences in the magnitude of decrease in age at onset between paternal and maternal transmissions. The parental bias in the genetic anticipation implies that the genetic anticipation is intimately associated with the differences in meiotic instability of the CAG repeats between paternal and maternal transmissions.
"Sporadic " cases The diagnosis of "sporadic" cases of triplet repeat diseases, i.e. cases in patients with no family history of similar cases, has been extremely difficult, since the high penetrance rate of these diseases makes diagnosis of such cases difficult unless the disease is proven to be transmitted as an autosomal dominant trait. Wehave so far encountered 6 sporadic cases of DRPLA, in only one of which did we have the opportunity to analyze genomic DNAof both parents (20, 25). The patient began experiencing generalized epileptic seizures at the age of 26, and began exhibiting ataxia and involuntary movementssuch as choreoathetosis at the age of 37. She was found to carry an expanded CAGrepeat of 62 repeat units of the DRPLAgene. Although neither of her parents showed any clinical abnormalities at the ages of 65 and 67, her father was found to carry a mildly expanded CAGrepeat of 57 repeat units of the DRPLA gene. With this intergenerational increase of 5 repeat units during the paternal transmission, the patient was the first to cross the phenotypic threshold in this pedigree. This showsthat sporadic cases can occur even in the absence of a family history of DRPLA. In the above family, the intergenerational increase in the number of the CAGrepeat units in the paternal transmission resulted in the appearance of the sporadic case. In the case of HD,expansion from an "intermediate range" allele to a fully expanded allele has been described. Although no cases of DRPLAwith expansion from an intermediate range allele to a fully expanded allele have been described, manymore sporadic cases should be analyzed to clarify the molecular mechanismsunderlying this occurrence.
Instability of GAGRepeats
As described above, CAGrepeats have been shown to exhibit meiotic as well as mitotic instability. The molecular mechanisms of the instability, however, are unknown. Recently we observed an interesting phenomenonregarding the meiotic instability of the CAGrepeat of the MJD1gene, the causative gene for MJD.There are two polymorphic loci, one within the CAGrepeat and the other immediately downstream of the CAG repeat of the MJD1gene (15). Wedeveloped a novel method to distinguish these polymorphisms with the use of allele-speciflc oligonucleotide probes (26) . The genomic fragments containing the CAGrepeat of the MJD1 gene were amplified by polymerase chain reaction (PCR) and the PCRproducts were separated through agarose or polyacrylamide gels and blotted onto nitrocellulose membranes, followed by allele-speciflc oligonucleotide hybridization. This method allows determination of haplotypes without the need for pedigree analysis. We investigated whether the polymorphism in cis or in trans to the expanded allele affects the intergenerational instability of the CAGrepeat of the MJD1 gene.
Wefound that the polymorphismin trans to the expanded CAG repeat has a substantial influence on the degree of intergenerational instability of the CAGrepeat. This result indicates that inter-allelic interaction occurs between the normal and expanded alleles. Comparing this phenomenon with that observed for the humanminisatellite MS32(27), we hypothesize that a gene conversion event is involved in the intergenerational instability of the CAGrepeat of the MJD1 gene. Theoccurrence of a gene conversion event in the case of contraction of a CTGrepeat of the myotonin kinase gene has also been described (28, 29) . These findings suggest that gene conversion events occur as a fundamentalmechanismof meiotic instability of the CAGrepeat in diseases caused by triplet repeat expansion. Somatic mosaicism has been detected in various regions of autopsied tissues of patients with CAGrepeat expansion diseases. The presence of a smaller CAGrepeat in the cerebellum than in other regions of the central nervous system wasfirst detected in two cases of HDwith unusually early ages at onset (30) . Since the cerebellum is the least involved central nervous system region in HD, it has been suggested that the presence of a smaller CAGrepeat in the cerebellum than in other regions of the central nervous system mayinhibit the pathological process in the cerebellum (30) . Subsequent studies on t)RPLA (3 1 , 32), Recently Ikeda et al reported that COScells transfected with truncated MJDCDNA with an expanded CAGrepeat undergo apoptosis (35) . They proposed that the expanded polyglutamine tract, but not the normal polyglutamine tract, is markedly toxic to COScells, and suggested that a difference in processing of the product of MJD1gene amongcells of various lineages may be the reason for the difference in distribution of affected regions. Since only the central nervous system is involved in diseases caused by CAGrepeat expansion such as DRPLAand MJD,it is unclear whether such marked toxicity demonstrated in COScells underlies the neurodegeneration in these diseases. Recently, it has been suggested that huntingtin, the product of the gene for HD, may be a substrate for apopain (36). Apopainis the humancounterpart of the nematodecysteine protease death-gene product CED-3 (36) and was proposed to be involved in the proteolytic processing ofhuntingtin. Goldberg et al reported that the rate of cleavage of huntingtin increases with the length of the polyglutamine tract of huntingtin (36). It is intriguing to hypothesize that a thus truncated protein containing the polyglutamine tract is toxic to neuronal cells. Ikeda et al also reported that expanded polyglutamine tracts are toxic to neuronal cells in a transgenic mouseand a cell culture system using truncated MJDCDNA (35) . Taken together, the findings suggest that processing of gene products with an expanded polyglutamine tract and the toxicity of the processed products play key roles in neurodegeneration.
Conclusion
As discussed in the present review, there are a number of challenging issues regarding the molecular mechanisms of neurodegeneration caused by expansion of triplet repeats. Since the molecular structures of the causative genes for triplet repeat diseases have been elucidated, triplet repeat disease models are no doubt the best model systems for investigation of the pathophysiology ofneurodegenerative diseases , and it is strongly expected that creation of animal models of humantriplet repeat diseases and development of cell culture systems for investigation of neuronal toxicity caused by triplet repeat expansions will be useful in the development of therapeutic measures for triplet repeat diseases.
